Search results
Showing 781 to 795 of 2548 results for methods
Tolebrutinib for treating non-relapsing secondary progressive multiple sclerosis ID6351
In development Reference number: GID-TA11333 Expected publication date: TBC
Low-dose atropine eye drops for treating myopia in people 3 to 14 years [ID6517]
In development Reference number: GID-TA11669 Expected publication date: 03 September 2026
In development Reference number: GID-QS10177 Expected publication date: TBC
Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women.
View recommendations for TA160Show all sections
In development Reference number: GID-TA11613 Expected publication date: TBC
In development Reference number: GID-TA11230 Expected publication date: 22 April 2026
In development Reference number: GID-TA11379 Expected publication date: TBC
In development Reference number: GID-TA11140 Expected publication date: TBC
In development Reference number: GID-TA10575 Expected publication date: 22 April 2026
Lifileucel for previously treated unresectable or metastatic melanoma ID3863
In development Reference number: GID-TA10752 Expected publication date: 10 July 2026
Awaiting development Reference number: GID-HST10067 Expected publication date: TBC
a means to monitor asthma control in adults, young people and children? Methods of tele-healthcare can include telephone interview (with...
In development Reference number: GID-QS10197 Expected publication date: 27 February 2026
This guideline covers the diagnosis and management of diverticular disease in people aged 18 years and over. It aims to improve diagnosis and care and help people get timely information and advice, including advice about symptoms and when to seek help.
Evidence-based recommendations on talquetamab (Talvey) for treating relapsed and refractory multiple myeloma after 3 or more treatments in adults.